CHRM2 and atrial fibrillation: Autoantibodies against M2-muscarinic receptor (anti-M2-R) are closely related to the occurrence and development of AF (10–13), and we found that anti-M2-R was one of the independent factors for the recurrence of AF during the 1-year follow-up (10).